Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte.
Dumaine, Cécile
Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte. [electronic resource] - Joint bone spine Jan 2020 - 49-55 p. digital
Publication Type: Journal Article
1778-7254
10.1016/j.jbspin.2019.07.011 doi
Adalimumab--therapeutic use
Antirheumatic Agents--adverse effects
Arthritis, Juvenile--drug therapy
Biological Products--adverse effects
Child
Etanercept--therapeutic use
Humans
Infections--epidemiology
Retrospective Studies
Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte. [electronic resource] - Joint bone spine Jan 2020 - 49-55 p. digital
Publication Type: Journal Article
1778-7254
10.1016/j.jbspin.2019.07.011 doi
Adalimumab--therapeutic use
Antirheumatic Agents--adverse effects
Arthritis, Juvenile--drug therapy
Biological Products--adverse effects
Child
Etanercept--therapeutic use
Humans
Infections--epidemiology
Retrospective Studies